Logo
Logo
Cost Curve
LOGIN
SUBSCRIBE

Cost Curve

Everything drug pricing and policy, every day


M3P
Employer Costs
GLP-1
340B
Payers Say COVID and Flu Vaccine Reimbursements Will Remain Solid, Regardless of CDC Changes

Payers Say COVID and Flu Vaccine Reimbursements Will Remain Solid, Regardless of CDC Changes

And Trump’s overseas visit puts a new lens on the industry-vs-government showdown in the UK

Brian Reid
Brian Reid
Sep 18, 2025
Paid
The Second-Day Reaction to the DTC Letters: Oprah Gets a Look, Pharma Gets Targeted, and FDA’s Capacity Gets Questioned

The Second-Day Reaction to the DTC Letters: Oprah Gets a Look, Pharma Gets Targeted, and FDA’s Capacity Gets Questioned

I’m out of position today, but you should be tracking on 340B news and odds that PBM reform happens this year

Brian Reid
Brian Reid
Sep 17, 2025
A Smart Tufts CEVR Look at Every Cost-Effectiveness Analysis Published for the Meds CMS Is Currently ‘Negotiating'

A Smart Tufts CEVR Look at Every Cost-Effectiveness Analysis Published for the Meds CMS Is Currently ‘Negotiating'

And a gathering of congressional staffers and health policy pros in Washington on MFN offers little perspective on next steps

Brian Reid
Brian Reid
Sep 16, 2025
Paid
The UK Abandoned Biopharma Innovation. Now Biopharma Is Abandoning the UK

The UK Abandoned Biopharma Innovation. Now Biopharma Is Abandoning the UK

And looking at how Eisai talked value around the launch of its subcutaneous Alzheimer’s drug

Brian Reid
Brian Reid
Sep 15, 2025
Paid
Was the White House’s Attack on DTC Advertising Fueled by Robots?

Was the White House’s Attack on DTC Advertising Fueled by Robots?

And the Washington Post, NPR, Axios, and CNBC all jumped on the biggest story in health policy right now

Brian Reid
Brian Reid
Sep 12, 2025
Paid
340B Remains In the Spotlight, With New Legislation, Court Battles, and the Pending Rebate Model Launch

340B Remains In the Spotlight, With New Legislation, Court Battles, and the Pending Rebate Model Launch

And how a small biotech is leading the way in talking about contracting for its medicine

Brian Reid
Brian Reid
Sep 11, 2025
Paid
I’m Not Sure Where to Begin Today. Health Costs? 340B? DTC Ads? Patent Shenanigans?

I’m Not Sure Where to Begin Today. Health Costs? 340B? DTC Ads? Patent Shenanigans?

It’s a drinking-from-a-firehose kind of morning

Brian Reid
Brian Reid
Sep 10, 2025
Paid
Hospitals Allege 340B Collusion in a Context-Free Letter to the DOJ and FTC

Hospitals Allege 340B Collusion in a Context-Free Letter to the DOJ and FTC

And is PBM reform about to mount a comeback? (I mean, the answer is pretty much “no,” but the topic is circulating again)

Brian Reid
Brian Reid
Sep 9, 2025
Paid
The Complexity of COVID Vaccine Regulation Is Hampering Patient Access

The Complexity of COVID Vaccine Regulation Is Hampering Patient Access

Plus a raft of 340B items, with rebate models and society-wide costs grabbing my attention

Brian Reid
Brian Reid
Sep 8, 2025
Paid
arrow-down
Load More

Everything drug pricing and policy, every day.


Posts Author

© 2025 Brian Reid.

Privacy policy

Terms of use

Powered by beehiiv